3,600 patients with neurotoxic symptoms in Damascus hospitals on Wednesday – Doctors Without Borders
However, MSF could not “scientifically confirm the cause of these symptoms”.
However, MSF could not “scientifically confirm the cause of these symptoms”.
It follows from the report that MSF will now replenish “empty stocks” and deliver additional medical supplies.
“In addition to 1,600 vials of atropine supplied over recent months, MSF has now dispatched 7,000 additional vials to facilities in the area. Treatment of neurotoxic patients is now being fully integrated into MSF’s medical strategies in all its programs in Syria,” stated Janssens.
It follows from the report that MSF will now replenish “empty stocks” and deliver additional medical supplies.
“In addition to 1,600 vials of atropine supplied over recent months, MSF has now dispatched 7,000 additional vials to facilities in the area. Treatment of neurotoxic patients is now being fully integrated into MSF’s medical strategies in all its programs in Syria,” stated Janssens.
“In addition to 1,600 vials of atropine supplied over recent months, MSF has now dispatched 7,000 additional vials to facilities in the area. Treatment of neurotoxic patients is now being fully integrated into MSF’s medical strategies in all its programs in Syria,” stated Janssens.
Syria is yet to give its assent to the UN inspectors currently in the country, who have not yet visited the sites of the alleged assault.









